NorthWest Biotherapeutics Inc (NWBO)

[jammyjames]

You're assuming idh positive mutants have a 60% chance of getting to 60months. It's more like 30% at most so the difference is minimal.

I very much doubt they have this subset analysis in the sap anyway (well only as exploratory) since the number of patients isn't high enough to get statistical significance given the amount of multiplicity. It's basically going to be a full ITT analysis that counts.